Indivior Pharmaceuticals, Inc. (INDV)

Pharmaceutical Preparations

Latest Price

$34.22

TTM P/E

12.27

Normalized P/E

25.69

Div Yield

Book Value

P/B Ratio

Valuation metrics

Norm. op. income: $32M (median of 3yr)

Tax rate: 45%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$0.63

98% downside

EPS: $1.64

Target P/E: 26×

Formula: EPS × P/E

P/E Fair Value

$42.64

+25% upside

100.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	18.71M	$767.0M	15.72%	+167.2K	2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC	7.57M	$310.0M	6.36%	-319.5K	2026-06-30
OAKTREE CAPITAL MANAGEMENT LP	6.13M	$251.0M	5.15%	--	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	5.50M	$225.0M	4.62%	-91.1K	2026-06-30
STATE STREET CORP	4.99M	$204.0M	4.20%	+88.1K	2026-06-30
FULLER & THALER ASSET MANAGEMENT, INC.	4.62M	$189.0M	3.88%	+86.2K	2026-06-30
Two Seas Capital LP	3.48M	$142.0M	2.92%	-1.27M	2026-06-30
MORGAN STANLEY	3.40M	$139.0M	2.85%	-110.1K	2026-06-30
FRANKLIN RESOURCES INC	3.32M	$136.0M	2.79%	+3.20M	2026-06-30
GEODE CAPITAL MANAGEMENT, LLC	3.16M	$129.0M	2.66%	+234.2K	2026-06-30